Estar Medical was founded in 1992 by Aaron Esteron - a polymer-science expert, entrepreneur and prolific inventor. Aaron, a pioneer in the development of vacuum collection and separation systems for blood and urine, was one of the first in the world to commercialize this line of products, which is currently being manufactured both in Israel and abroad.
From 2008, Estar Medical has taken a huge technological leap forward by investing in the creation and development of its own state of the art proprietary technologies and systems for the Regenerative Medicine arena. The flagship product of Estar’s in-house development is the Tropocells® Platelet Preparation System for the separation of platelet concentrate (PRP) from the patient's own blood.
Estar Medical produces, manufactures and distributes the Tropocells® PRP System and the Cellenis® PRP System, both under these privately owned brand names as well as under the "Mycells" brand name in more than 50 countries worldwide, including in the US, under the brand name of "Eclipse PRP". Estar Medical prides itself of being totally committed to the innovation and quality of its unique technology as well as for creating the next generation of its proprietary Tropocells® platform.